SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.55 |
| Enterprise Value ($M) | 14.06 |
| Book Value ($M) | 0.83 |
| Book Value / Share | 0.18 |
| Price / Book | 11.55 |
| NCAV ($M) | -0.05 |
| NCAV / Share | -0.01 |
| Price / NCAV | -176.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.64 |
| Return on Assets (ROA) | -1.58 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.03 |
| Current Ratio | 1.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 26.25 |
| Assets | 27.13 |
| Liabilities | 26.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -33.84 |
| Net Income | -35.81 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -29.55 |
| Cash from Investing | 14.48 |
| Cash from Financing | 21.23 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Carlyle Group Inc. | 4.10 | -96.00 | |
| 13G/A | Pfizer Inc | 3.47 | 0.00 | |
| 13G/A | Sectoral Asset Management Inc | 3.70 | 0.00 | |
| 13G/A | Sr One Capital Management, Llc | 0.00 | -100.00 | |
| 13G/A | Altitude Life Science Ventures Fund II, L.P. | 4.40 | 0.00 | |
| 13D/A | Column Group Ii, Lp | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,758 | 101,913 | 16.44 | |
| 25,951 | 12,601 | 205.94 | |
| 46,721 | 9,210 | 507.29 | |
| 34,505 | 28,051 | 123.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DTIL – Precision BioSciences, Inc. | DYAI – Dyadic International, Inc. |
| EDSA – Edesa Biotech, Inc. | ELDN – Eledon Pharmaceuticals, Inc. |
| ELUT – Elutia Inc. |
Financial data and stock pages provided by
Fintel.io